arXiv AI

Multimodal Ordinal Modeling of Alzheimer's Disease Severity Using Structural MRI and Clinical Data

arXiv:2606. 11794v1 Announce Type: cross Abstract: Neurodegenerative diseases such as Alzheimer's disease (AD) require accurate and scalable tools for assessing disease severity, yet current clinical staging remains time-intensive and prone to variability.

arXiv Computer Vision
Sep 14

A Multimodal Explainable Deep Learning Framework for Alzheimer's Disease Diagnosis using 3D Magnetic Resonance Imaging and Clinical Data

The study presents an explainable multimodal deep‑learning framework that combines a 3D CNN for T1‑weighted MRI with a feedforward network for harmonized clinical and demographic data to diagnose Alzheimer’s disease. Using 6,479 ADNI records and 1,703 OASIS‑3 records, the authors compare various model configurations on three‑way and pairwise diagnostic tasks, finding that performance and explanations vary by task, modality, fusion strategy, and cohort. SHAP and Integrated Gradients consistently highlight the MMSE score as the most influential tabular feature, while CAM‑based explanations differ across model setups and cohorts, indicating that explainability is not a stable property under cohort shift.

By Yusuf Brima, Marcellin Atemkeng, Lakshmana Rao Namamula, Antoine Vacavant
arXiv Machine Learning
Jul 14

Imputation-free transformer learning enables robust Alzheimer's disease prediction and calibrated uncertainty quantification across heterogeneous clinical cohorts

arXiv:2607. 11656v1 Announce Type: cross Abstract: Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of real-world clinical data.

By Christelle Schneuwly Diaz, Narmina Baghirova, Duy-Thanh Vu, Duy-Cat Can, Gilles Allali, Philippe Ryvlin, Oliver Y. Ch\'en
arXiv Computer Vision
Aug 31

3D MRI-Based Alzheimer's Disease Classification Using Multi-Modal 3D CNN with Leakage-Aware Subject-Level Evaluation

The paper presents a multimodal 3D convolutional neural network that classifies Alzheimer’s disease using raw OASIS 1 MRI volumes. It fuses structural T1 images with gray matter, white matter, and cerebrospinal fluid probability maps to capture complementary neuroanatomical information. Evaluated with 5‑fold subject‑level cross‑validation, the model achieves a mean accuracy of 72.34 % and an ROC AUC of 0.7781, with GradCAM visualizations highlighting anatomically relevant regions such as the medial temporal lobe and ventricles.

By Md Sifat, Sania Akter, Akif Islam, Md. Ekramul Hamid, Abu Saleh Musa Miah, Najmul Hassan, Md Abdur Rahim, Jungpil Shin
arXiv Machine Learning
Sep 23

MMAP: Multimodal Missing-Aware Pretraining for Longitudinal Alzheimer's Prediction

MMAP is a Multimodal Missing‑Aware Alignment Pretraining method designed to learn image‑tabular representations from incomplete data. It uses a sigmoid contrastive learning image encoder with generative reconstruction, a tabular encoder based on a foundation model, and a missing token generator to handle missing modalities. The approach is evaluated on longitudinal Alzheimer’s tasks—predicting disease stage conversion and amyloid status—and outperforms both multimodal and unimodal baselines.

By Fiona Kekwick, Matthew Baugh, Bernhard Kainz, Paul M. Matthews, Wenjia Bai
arXiv Computer Vision
2d ago

A Two-Scan Deep Learning Model for Predicting Dementia in Mild Cognitive Impairment

The paper introduces TAFNet, a temporal attention fusion network that uses both a baseline and a follow‑up T1‑weighted brain scan to predict which individuals with mild cognitive impairment (MCI) will progress to dementia. The model employs a pretrained Siamese encoder for each scan and fuses the two scans through anatomical difference, cross‑temporal attention, joint context, and a learned per‑patient gate. Evaluated on paired scans from the Alzheimer’s Disease Neuroimaging Initiative, TAFNet outperforms single‑scan networks and a simple scan‑difference model, achieving significant gains in cross‑validation and maintaining high sensitivity at clinically reasonable specificity.

By Sara Fin, Alireza Moayedikia, David J. White, Uffe Kock Wiil, Alicia Troncoso